Targeting Cardio-Metabolic Diseases and Metabolomics in Drug Discovery – CHI’s 14th Annual Discovery On Target September 19-22, 2016 | Westin Boston Waterfront — Boston, MA
Reporter: Aviva Lev-Ari, PhD, RN
14th Annual Discovery On Target
|
2016 Prospectus Download | Current Sponsors | Current Exhibitors & Floorplan |
Hello Aviva,
I wanted to inform you of the opportunity to meet with thought leaders at the 14th Annual Discovery On Target event, taking place September 19-22, 2016 in Boston attending the Targeting Cardio-Metabolic Diseases and Metabolomics in Drug Discovery conference programs. As a sponsor and/or exhibitor of this meeting, you have the opportunity to speak and network with 1,100+ attendees from 20+ countries composed of scientists, executives, directors, and managers from large biotech and pharmaceutical companies.
Delivering a sponsored presentation during the conference program is the most effective way to access even the hardest-to-reach decision makers from within your target market. This will increase your scientific presence and drive more qualified leads to your booth space, maximizing your ROI.
Please see the session topics, below:
This conference focuses on new cardiometabolic drug targets, mostly PCSK9 and the connections between cardiometabolic disease and liver metabolism, especially as manifested in a disease of the fatty liver, NASH (Non-Alcoholic SteatoHepatitis).
Topics include:
- New Cardiometabolic Drug Targets and PCSK9
- NASH: Non-Alcohlic Steatohepatitis and Cardiometabolism
This conference will emphasize presentations that analyze metabolomics data in a larger context of cellular functioning or disease states. A few introductory type presentations will highlight the current state of the field and its major technologies.
Topics include:
- Metabolomics Overview and Technologies
- Disease-Focused Research Stemming from the Metabolomic Analysis
- Cancer Metabolism
Opportunities are available for sponsored presentations during the conference agenda, One-on-One Meetings, and exhibit opportunities. Act now, as priority placement is given to companies who sign on early. We can customize a sponsorship package to meet your company’s needs and reach your target audience. Thank you for your time and I look forward to hearing from you!
Kind regards,
Jon Stroup
Senior Manager, Business Development
T: 781.972.5483
F: 781.972.5452
E: jstroup@cambridgeinnovationinstitute.com
W: DiscoveryOnTarget.com
Follow us:
SPONSORSHIP & EXHIBIT INFORMATION
2016 Prospectus Now Available!
PREMIER SPONSOR
SOURCE
From: Jon Stroup <sales2@healthtech.com>
Date: Monday, June 13, 2016 at 2:40 PM
To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>
Subject: Targeting Cardio-Metabolic Diseases & Metabolomics in Drug Discovery
Leave a Reply